Bioventus Inc.Bioventus Inc.Bioventus Inc.

Bioventus Inc.

No trades
See on Supercharts
Next report date
Report period
EPS estimate
Revenue estimate
Market capitalization
‪507.14 M‬USD
−0.34USD
‪−156.23 M‬USD
‪512.35 M‬USD
‪36.31 M‬
Beta (1Y)
1.38

About Bioventus Inc.

CEO
Robert Claypoole
Headquarters
Durham
Employees (FY)
970
Founded
2011
FIGI
BBG00D8550B3
Bioventus, Inc. is a medical technology company, which focuses on developing and commercializing and proprietary orthobiologic products for the treatment of patients suffering from an array of musculoskeletal conditions. It operates through the following business segments: Active Healing Therapies-U.S, Active Healing Therapies-International, Surgical and BMP. The Active Healing Therapies-U.S and International offers two types of non-surgical products which are non-invasive exogen system for long bone stimulation for fracture healing and hyaluronic acid, or HA, viscosupplementation therapies for osteoarthritis pain relief. The Surgical segment offers a portfolio of advanced bone graft substitutes. The BMP segment comprises proprietary next-generation bone morphogenetic protein, or BMP. The company was founded on November 23, 2011 and is headquartered in Durham, NC.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of BVS is 6.37 USD — it has increased by 0.63% in the past 24 hours. Watch Bioventus Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Bioventus Inc. stocks are traded under the ticker BVS.
BVS stock has fallen by 5.77% compared to the previous week, the month change is a 50.59% rise, over the last year Bioventus Inc. has showed a 140.38% increase.
We've gathered analysts' opinions on Bioventus Inc. future price: according to them, BVS price has a max estimate of 9.00 USD and a min estimate of 8.00 USD. Watch BVS chart and read a more detailed Bioventus Inc. stock forecast: see what analysts think of Bioventus Inc. and suggest that you do with its stocks.
BVS reached its all-time high on Jun 28, 2021 with the price of 19.94 USD, and its all-time low was 0.80 USD and was reached on Mar 31, 2023. View more price dynamics on BVS chart.
See other stocks reaching their highest and lowest prices.
BVS stock is 2.32% volatile and has beta coefficient of 1.38. Track Bioventus Inc. stock price on the chart and check out the list of the most volatile stocks — is Bioventus Inc. there?
Today Bioventus Inc. has the market capitalization of ‪406.58 M‬, it has increased by 1.01% over the last week.
Yes, you can track Bioventus Inc. financials in yearly and quarterly reports right on TradingView.
Bioventus Inc. is going to release the next earnings report on Aug 6, 2024. Keep track of upcoming events with our Earnings Calendar.
BVS earnings for the last quarter are 0.07 USD per share, whereas the estimation was −0.07 USD resulting in a 205.00% surprise. The estimated earnings for the next quarter are 0.07 USD per share. See more details about Bioventus Inc. earnings.
Bioventus Inc. revenue for the last quarter amounts to ‪129.46 M‬ USD despite the estimated figure of ‪118.37 M‬ USD. In the next quarter revenue is expected to reach ‪137.59 M‬ USD.
BVS net income for the last quarter is ‪−4.57 M‬ USD, while the quarter before that showed ‪−6.10 M‬ USD of net income which accounts for 25.03% change. Track more Bioventus Inc. financial stats to get the full picture.
No, BVS doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of May 28, 2024, the company has 970.00 employees. See our rating of the largest employees — is Bioventus Inc. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Bioventus Inc. EBITDA is ‪86.55 M‬ USD, and current EBITDA margin is 14.32%. See more stats in Bioventus Inc. financial statements.
Like other stocks, BVS shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Bioventus Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Bioventus Inc. technincal analysis shows the strong buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Bioventus Inc. stock shows the buy signal. See more of Bioventus Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.